NCT04367688View on ClinicalTrials.gov

HIV Pre-exposure Prophylaxis Implementation Hong Kong Study

CompletedOBSERVATIONAL
Enrollment

339

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

September 30, 2023

Study Completion Date

January 31, 2024

Conditions
HIV Infections
Interventions
DRUG

Tenofovir Disoproxil Fumarate 300 mg / emtricitabine 200 mg

daily use for PrEP

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04367688 - HIV Pre-exposure Prophylaxis Implementation Hong Kong Study | Biotech Hunter | Biotech Hunter